Value of diffusion-weighted MRI in diagnosis of uterine cervical cancer: a prospective study evaluating the benefits of DWI compared to conventional MR sequences in a 3T environment

Background Imaging of cervical carcinoma remains challenging as local infiltration of surrounding tissues cannot always be discriminated safely. New imaging techniques, like diffusion-weighted imaging (DWI) have emerged, which could lead to a more sensitive tumor detection. Purpose To evaluate the benefits of DWI for determination of size, local infiltration, and tumor grading, in patients with primary and recurrent cervical cancer. Material and Methods In this prospective, study we enrolled 50 patients with primary (n = 35) and recurrent (n = 15) tumors. All patients underwent 3T magnetic resonance imaging (MRI) including conventional (e.g. T1/T2 ± fs ± contrast) sequences and DWI (b-values of 0, 50, 400, 800 s/mm2). All images were analyzed by three readers with different experience levels (1, 3, 6 years), who compared image quality, tumor delineation, dimensions, local infiltration, lymph node involvement, and quantified ADC values compared to the histopathological grading. Results Additional use of DWI resulted in significantly better (P < 0.001) tumor delineation for the least experienced reader, but not for experienced readers. Tumor dimensions were assessed almost equally (P > 0.05) in conventional sequences and DWI. Use of DWI led to an increase in sensitivity of infiltrated adjacent tissue (from 86% to 90%) and detection of lymph node metastases (from 47% to 67%). Quantitative assessment of carcinomas showed lower ADC values (P < 0.001) with significant inverse correlations between different grading levels. Conclusion Our study demonstrates the overall benefits using DWI in 3T MRI resulting in a higher reader confidence, sensitivity of tissue infiltration, and tumor-grading for cervical cancer.

[1]  E. Sala,et al.  Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology , 2011, European Radiology.

[2]  K. Togashi,et al.  Diffusion‐weighted MR imaging of uterine endometrial cancer , 2007, Journal of magnetic resonance imaging : JMRI.

[3]  E. Sala,et al.  Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2012, Radiology.

[4]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[5]  P. Bhosale,et al.  Role of Magnetic Resonance Imaging as an Adjunct to Clinical Staging in Cervical Carcinoma , 2010, Journal of computer assisted tomography.

[6]  Patrick M M Bossuyt,et al.  Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. , 2003, Gynecologic oncology.

[7]  N. deSouza,et al.  Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. , 2013, AJR. American journal of roentgenology.

[8]  L. Horn,et al.  (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy. , 2012, Gynecologic oncology.

[9]  T. Cheung,et al.  Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. , 2000, AJR. American journal of roentgenology.

[10]  A. Rockall,et al.  MRI and PET Scans for Primary Staging and Detection of Cervical Cancer Recurrence , 2010, Women's health.

[11]  S. Marnitz,et al.  Aspects of Therapy for Cervical Cancer in Germany 2012 - Results from a Survey of German Gynaecological Hospitals. , 2013, Geburtshilfe und Frauenheilkunde.

[12]  Mustafa Koplay,et al.  Comparison of apparent diffusion coefficient values among different MRI platforms: a multicenter phantom study. , 2013, Diagnostic and interventional radiology.

[13]  R. Barakat,et al.  Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer. , 2013, Gynecologic oncology.

[14]  M. Amin,et al.  Protocol for the examination of specimens from patients with carcinomas of the cervix: A basis for checklists , 1999 .

[15]  Y. Liu,et al.  Grading of uterine cervical cancer by using the ADC difference value and its correlation with microvascular density and vascular endothelial growth factor , 2012, European Radiology.

[16]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[17]  L. G. Koss,et al.  Cervical Cancer , 1981, Current Topics in Pathology.

[18]  Y. Huan,et al.  The value of apparent diffusion coefficient in the assessment of cervical cancer , 2013, European Radiology.

[19]  M. Mix,et al.  Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. , 2001, Radiology.

[20]  M. Kataoka,et al.  MRI of the female pelvis at 3T compared to 1.5T: Evaluation on high‐resolution T2‐weighted and HASTE images , 2007, Journal of magnetic resonance imaging : JMRI.

[21]  A. Bats,et al.  Accuracy of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography in the Pretherapeutic Detection of Occult Para-aortic Node Involvement in Patients with a Locally Advanced Cervical Carcinoma , 2011, Annals of Surgical Oncology.

[22]  M. Picchio,et al.  Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? , 2011, Gynecologic oncology.

[23]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[24]  L. Horn,et al.  Total mesometrial resection: High resolution nerve-sparing radical hysterectomy based on developmentally defined surgical anatomy , 2003, International Journal of Gynecologic Cancer.

[25]  B. Hentschel,et al.  Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. , 2007, Gynecologic oncology.